Menu Close

Articles on Pharmaceuticals

Displaying 1 - 20 of 201 articles

Canadians pay high drug prices, but the pharmaceutical industry claims it is a ‘key partner in economic resilience, recovery and growth.’ (Shutterstock)

High drug prices in Canada are just one side of a bad equation

Canadians pay very high drug costs, but Canada also does not receive the same economic benefits from pharmaceutical industry investments as other countries do.
Health Canada’s new drug licensing proposal contains no mechanism for making fast-tracked medicines affordable. THE CANADIAN PRESS/Ryan Remiorz

Canada’s misguided changes to drug regulation could fast-track unproven medications and divert funds from other health needs

The federal government’s proposed Agile Licensing drug approval regulations mean Canada will have less information about the risks of new medicines, and higher costs.
Ozempic, a semaglutide drug being used for weight loss, could impact how society sees fat people. (macrovector/Freepik)

Listen: Widespread use of Ozempic for weight loss could change how we view fatness

As the use of Ozempic, a drug for diabetes, slams into the mainstream as a weight-loss method, will the drug’s use impact our concept of fatness? And how does fatness intersect with race and class?
When regulatory agencies like Health Canada approve a new drug, they require the drug company to continue monitoring the product’s safety. (Shutterstock)

Health Canada should be transparent about how it’s monitoring drug safety

Health Canada continues to monitor newly approved drugs to determine if the benefits identified in the pre-market trials hold up to further scrutiny. Canadians need better access to that information.
Drug patents don’t necessarily spur companies to innovate so much as restrict access to their IP. Andrii Zastrozhnov/iStock via Getty Images Plus

Pharma’s expensive gaming of the drug patent system is successfully countered by the Medicines Patent Pool, which increases global access and rewards innovation

The Medicines Patent Pool was created to promote public health, facilitating generic licensing for patented drugs that treat diseases predominantly affecting low- and middle-income countries.

Top contributors

More